BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36580755)

  • 21. Size of Sentinel Node Metastasis Predicts Non-sentinel Node Involvement in Endometrial Cancer.
    Baiocchi G; Mantoan H; Gonçalves BT; Faloppa CC; Kumagai LY; Badiglian-Filho L; da Costa AABA; De Brot L
    Ann Surg Oncol; 2020 May; 27(5):1589-1594. PubMed ID: 31686340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
    Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
    J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer.
    Touhami O; Trinh XB; Gregoire J; Sebastianelli A; Renaud MC; Grondin K; Plante M
    Gynecol Oncol; 2015 Jul; 138(1):41-5. PubMed ID: 25891803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure.
    Stephens AJ; Kennard JA; Fitzsimmons CK; Manyam M; Kendrick JE; Singh C; McKenzie ND; Ahmad S; Holloway RW
    Int J Gynecol Cancer; 2020 Mar; 30(3):305-310. PubMed ID: 31857439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Sentinel Lymph Node Mapping in High-grade Endometrial Cancer.
    Yu R; Matthews BJ; Beavis AL
    Curr Treat Options Oncol; 2022 Oct; 23(10):1339-1352. PubMed ID: 35980519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: An Italian retrospective analysis of two reference centers.
    Buda A; Di Martino G; Restaino S; De Ponti E; Monterossi G; Giuliani D; Ercoli A; Dell'Orto F; Dinoi G; Grassi T; Scambia G; Fanfani F
    Gynecol Oncol; 2017 Dec; 147(3):528-534. PubMed ID: 29032824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.
    Schlappe BA; Weaver AL; Ducie JA; Eriksson AGZ; Dowdy SC; Cliby WA; Glaser GE; Soslow RA; Alektiar KM; Makker V; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2018 Nov; 151(2):235-242. PubMed ID: 30177461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel Lymph Node Mapping vs Systematic Lymphadenectomy for Endometrial Cancer: Surgical Morbidity and Lymphatic Complications.
    Accorsi GS; Paiva LL; Schmidt R; Vieira M; Reis R; Andrade C
    J Minim Invasive Gynecol; 2020; 27(4):938-945.e2. PubMed ID: 31421249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The detection of sentinel lymph nodes in laparoscopic surgery can eliminate systemic lymphadenectomy for patients with early stage endometrial cancer.
    Tanaka T; Terai Y; Fujiwara S; Tanaka Y; Sasaki H; Tsunetoh S; Yamamoto K; Yamada T; Ohmichi M
    Int J Clin Oncol; 2018 Apr; 23(2):305-313. PubMed ID: 29098518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis.
    Lee D; Kim YN; Cho SH; Yoon HS; Kim YT; Kim S; Kim SW
    J Gynecol Oncol; 2023 Nov; 34(6):e79. PubMed ID: 37477102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study - a multicentric analysis of predictors of failed mapping.
    Sozzi G; Fanfani F; Berretta R; Capozzi VA; Uccella S; Buono N; Giallombardo V; Di Donna MC; Monterossi G; Restaino S; Capasso I; Dinoi G; Scambia G; Chiantera V
    Int J Gynecol Cancer; 2020 Nov; 30(11):1713-1718. PubMed ID: 32868384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A large multicenter propensity match study of sentinel lymph node biopsy feasibility in endometrioid variants of endometrial cancer.
    Capozzi VA; Rosati A; Vargiu V; Sozzi G; Cosentino F; Chiantera V; Scambia G; Berretta R; Fanfani F
    Eur J Surg Oncol; 2022 Jun; 48(6):1390-1394. PubMed ID: 35120817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study.
    Bjørnholt SM; Mogensen O; Bouchelouche K; Sponholtz SE; Parner ET; Hildebrandt MG; Loft A; Neumann G; Bjørn SF; Dahl K; Markauskas A; Frøding LP; Jensen PT
    Gynecol Oncol; 2024 Mar; 182():179-187. PubMed ID: 38335900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel preoperative predictive score to evaluate lymphovascular space involvement in endometrial cancer: an aid to the sentinel lymph node algorithm.
    Capozzi VA; Sozzi G; Uccella S; Ceni V; Cianciolo A; Gambino G; Armano G; Pugliese M; Scambia G; Chiantera V; Berretta R
    Int J Gynecol Cancer; 2020 Jun; 30(6):806-812. PubMed ID: 32284322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
    Schlappe BA; Weaver AL; McGree ME; Ducie J; Zahl Eriksson AG; Dowdy SC; Cliby WA; Glaser GE; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2020 Jan; 156(1):62-69. PubMed ID: 31776037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers.
    How JA; Frumovitz M; Stewart KI; Soliman PT
    Curr Oncol Rep; 2022 Nov; 24(11):1521-1529. PubMed ID: 35781863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer.
    Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Plante M
    Gynecol Oncol; 2017 Dec; 147(3):549-553. PubMed ID: 28942993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer.
    Matsuo K; Klar M; Khetan VU; Violette CJ; Youssefzadeh AC; Yessaian AA; Roman LD
    Eur J Obstet Gynecol Reprod Biol; 2022 Aug; 275():91-96. PubMed ID: 35763967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer.
    Kim YN; Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Int J Gynecol Cancer; 2020 Mar; 30(3):318-324. PubMed ID: 31992601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.
    Khoury-Collado F; St Clair C; Abu-Rustum NR
    Oncologist; 2016 Apr; 21(4):461-6. PubMed ID: 26961924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.